Intravenous Ketamine Quells Pain in Lyme Disease When Opiates and Other Drugs Fail

1 Star2 Stars3 Stars4 Stars5 Stars (4 votes, average: 4.50 out of 5)
Loading...

To read the entire article for free, click here.
 
Editor’s Note: Most Lyme-literate doctors consider “post-treatment Lyme disease syndrome” to be non-existent. Ongoing symptoms following short-term antibiotic therapy have been proven in studies to be signs of ongoing infection with Borrelia and co-infections, not just an ongoing inflammatory response of the immune system.
 
Abstract
 
Post-treatment Lyme disease syndrome (PTLDS) is a pain disorder for which there remains no gold standard treatment option. Here, we report a case of PTLDS in a female patient whose pain was refractory to treatment options such as radiofrequency ablation, vitamin infusion therapy, opioid analgesics, and other pharmacotherapies. The patient commenced an experimental intravenous ketamine infusion therapy at the Florida Spine Institute (Clearwater, FL, USA) and achieved relief from her chronic pain, an improved quality of life, reduced depression and suicidal ideation, and reduced opioid consumption.
 
Source: By Hanna AF1, Abraham B1, Hanna A1, Smith AJ1. Effects of intravenous ketamine in a patient with post-treatment Lyme disease syndrome. Int Med Case Rep J. 2017 Aug 18;10:305-308. doi: 10.2147/IMCRJ.S137975. eCollection 2017.
 

1 Star2 Stars3 Stars4 Stars5 Stars (4 votes, average: 4.50 out of 5)
Loading...



Leave a Reply